Mérédis Favreau
YOU?
Author Swipe
View article: Checkpoint inhibition in the treatment of multiple myeloma: A way to boost innate-like T cell anti-tumor function?
Checkpoint inhibition in the treatment of multiple myeloma: A way to boost innate-like T cell anti-tumor function? Open
View article: Correction: Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells
Correction: Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells Open
[This corrects the article DOI: 10.18632/oncotarget.18152.].
View article: Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells
Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells Open
Multiple myeloma (MM) is characterized by the accumulation of malignant plasma cells in the bone marrow (BM). Recently, several studies have highlighted the role of pathogens in either promoting or dampening malignancies of unrelated origi…
View article: Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition
Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition Open
Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibitionMucosal associated invariant T (MAIT) cells primarily contribute to immune defense against infectious pathogens a…
View article: Immune therapy in multiple myeloma : can iNKT cells be targeted?
Immune therapy in multiple myeloma : can iNKT cells be targeted? Open
Multiple myeloma (MM) is a plasma cell cancer where, despite the major therapeutic advances, still the majority of patients relapse and develop a non-responsive disease. Consequently, there’s an urgent need for the development of new treat…
View article: Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?
Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma? Open
Natural killer T (NKT) cells constitute a unique subset of innate-like T lymphocytes which differ from conventional T cells by recognizing lipid antigens presented by the non-polymorphic major histocompatibility complex (MHC) I-like molecu…